Palisade Bio announced a 1-for-15 reverse split of its common stock effective at 5:00 PM ET on Friday April 5, 2024. The reverse stock split was approved by Palisade Bio’s stockholders at the virtual special meeting of stockholders held on March 25, 2024. The reverse stock split is primarily intended to increase the Company’s per share trading price and bring the Company into compliance with the Nasdaq’s listing requirement regarding minimum share price.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PALI:
- Palisade Bio files to sell 3.63M shares of common stock for holders
- Palisade Bio, Inc.’s Success on the Line: The Critical Role of Retaining Top Talent Without Safeguards
- Palisade Bio reports FY23 EPS ($1.80) vs ($16.53) last year
- Palisade Bio to Present at Digestive Disease Week (DDW) 2024
- Palisade Bio’s Corporate Shake-Up Sparks Investor Interest
